No I don’t believe so, just a very tired one.
the clinical validation is there. It is also evident that the tests are being used, billed but not paid for. I personally find this a bit of a sham, considering they are using the test and not paying for it - then when the LCM is approved will negotiate a lower bulk payment for sure.
The amount of tests they currently do per year is worth more than the market cap at the agreed price.
the horse is not dead - just tired!
Add to My Watchlist
What is My Watchlist?
